92 related articles for article (PubMed ID: 18474077)
1. Activity, tolerability and efficacy of levetiracetam on cerebellar symptoms in multiple sclerosis patients: a pilot kinematic study.
Solaro C; Brichetto G; Capello E; Abuarqub S; Sanguineti V
Eur J Neurol; 2008 Jun; 15(6):619-26. PubMed ID: 18474077
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of levetiracetam on upper limb movement in multiple sclerosis patients with cerebellar signs: a multicenter double-blind, placebo-controlled, crossover study.
Solaro C; de Sire A; Messmer Uccelli M; Mueller M; Bergamaschi R; Gasperini C; Restivo DA; Stabile MR; Patti F
Eur J Neurol; 2020 Nov; 27(11):2209-2216. PubMed ID: 32558044
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study.
Striano P; Coppola A; Vacca G; Zara F; Brescia Morra V; Orefice G; Striano S
J Neurol; 2006 Jun; 253(6):762-6. PubMed ID: 16683063
[TBL] [Abstract][Full Text] [Related]
4. Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study.
Rossi S; Mataluni G; Codecà C; Fiore S; Buttari F; Musella A; Castelli M; Bernardi G; Centonze D
Eur J Neurol; 2009 Mar; 16(3):360-6. PubMed ID: 19364364
[TBL] [Abstract][Full Text] [Related]
5. Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor.
Handforth A; Martin FC
Mov Disord; 2004 Oct; 19(10):1215-21. PubMed ID: 15390011
[TBL] [Abstract][Full Text] [Related]
6. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
[TBL] [Abstract][Full Text] [Related]
7. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy.
Piazzini A; Chifari R; Canevini MP; Turner K; Fontana SP; Canger R
Epilepsy Res; 2006 Mar; 68(3):181-8. PubMed ID: 16332430
[TBL] [Abstract][Full Text] [Related]
9. An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome.
Fernández-Jaén A; Fernández-Mayoralas DM; Muñoz-Jareño N; Calleja-Pérez B
Eur J Paediatr Neurol; 2009 Nov; 13(6):541-5. PubMed ID: 19211282
[TBL] [Abstract][Full Text] [Related]
10. The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis.
Feys P; D'hooghe MB; Nagels G; Helsen WF
Mult Scler; 2009 Mar; 15(3):371-8. PubMed ID: 19168602
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam in tardive dyskinesia: an open label study.
Konitsiotis S; Pappa S; Mantas C; Mavreas V
Mov Disord; 2006 Aug; 21(8):1219-21. PubMed ID: 16637037
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam in patients with central neuropathic post-stroke pain--a randomized, double-blind, placebo-controlled trial.
Jungehulsing GJ; Israel H; Safar N; Taskin B; Nolte CH; Brunecker P; Wernecke KD; Villringer A
Eur J Neurol; 2013 Feb; 20(2):331-7. PubMed ID: 22925226
[TBL] [Abstract][Full Text] [Related]
13. A New Alternative Drug With Fewer Adverse Effects in the Treatment of Sydenham Chorea: Levetiracetam Efficacy in a Child.
Şahin S; Cansu A
Clin Neuropharmacol; 2015; 38(4):144-6. PubMed ID: 26166232
[TBL] [Abstract][Full Text] [Related]
14. Levetiracetam in social phobia: a placebo controlled pilot study.
Zhang W; Connor KM; Davidson JR
J Psychopharmacol; 2005 Sep; 19(5):551-3. PubMed ID: 16166192
[TBL] [Abstract][Full Text] [Related]
15. Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
Zesiewicz TA; Sullivan KL; Hauser RA; Sanchez-Ramos J
Mov Disord; 2006 Nov; 21(11):1998-2001. PubMed ID: 16941461
[TBL] [Abstract][Full Text] [Related]
16. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of primidone in reducing severe cerebellar tremors in patients with multiple sclerosis.
Naderi F; Javadi SA; Motamedi M; Sahraian MA
Clin Neuropharmacol; 2012; 35(5):224-6. PubMed ID: 22821064
[TBL] [Abstract][Full Text] [Related]
18. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
Stefan H; Wang-Tilz Y; Pauli E; Dennhöfer S; Genow A; Kerling F; Lorber B; Fraunberger B; Halboni P; Koebnick C; Gefeller O; Tilz C
Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam in migraine prophylaxis: a randomized placebo-controlled study in a rural medical institute in northern India.
Verma A; Srivastava D; Kumar A; Singh V
Clin Neuropharmacol; 2013; 36(6):193-7. PubMed ID: 24201237
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome.
Hedderick EF; Morris CM; Singer HS
Pediatr Neurol; 2009 Jun; 40(6):420-5. PubMed ID: 19433274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
